154 related articles for article (PubMed ID: 38444890)
1. Key programmatic and policy considerations for introducing multipurpose prevention (MPT) methods: reflections from healthcare providers and key stakeholders in South Africa.
Kutywayo A; Mataboge P; Mthimkhulu N; Martin CE; Muhwava LS; Mazibuko M; Makalela N; Kwatsha K; Butler V; Mullick S
Front Reprod Health; 2024; 6():1249750. PubMed ID: 38444890
[TBL] [Abstract][Full Text] [Related]
2. Preferences, educational messaging, and demand creation channels for multipurpose-prevention technologies (MPTs) among women in South Africa.
Mataboge P; Mthimkhulu N; Kutywayo A; Martin CE; Mazibuko M; Kwatsha K; Makalela N; Briedenhann E; Butler V; Bothma R; Mullick S
BMC Public Health; 2023 Oct; 23(1):2090. PubMed ID: 37880628
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of end-user research to inform future multipurpose prevention technologies in sub-Saharan Africa: a scoping review.
Bhushan NL; Ridgeway K; Luecke EH; Palanee-Phillips T; Montgomery ET; Minnis AM
Front Reprod Health; 2023; 5():1156864. PubMed ID: 37325244
[TBL] [Abstract][Full Text] [Related]
4. Lessons from reproductive health to inform multipurpose prevention technologies: don't reinvent the wheel.
Brady M; Manning J
Antiviral Res; 2013 Dec; 100 Suppl():S25-31. PubMed ID: 24188700
[TBL] [Abstract][Full Text] [Related]
5. Microarray patch for HIV prevention and as a multipurpose prevention technology to prevent HIV and unplanned pregnancy: an assessment of potential acceptability, usability, and programmatic fit in Kenya.
Gachigua SG; Karuga R; Ngunjiri A; Jarrahian C; Coffey PS; Kilbourne-Brook M; Otiso L
Front Reprod Health; 2023; 5():1125159. PubMed ID: 37168102
[TBL] [Abstract][Full Text] [Related]
6. Multipurpose prevention technologies for sexual and reproductive health: mapping global needs for introduction of new preventive products.
Schelar E; Polis CB; Essam T; Looker KJ; Bruni L; Chrisman CJ; Manning J
Contraception; 2016 Jan; 93(1):32-43. PubMed ID: 26385588
[TBL] [Abstract][Full Text] [Related]
7. Perspectives on sexual and reproductive health self-care among women, healthcare providers, and other key informants: a mixed-methods study in South Africa and Zambia.
Cartwright AF; Velarde M; Beksinska M; Smit J; Kasaro M; Tang JH; Milford C; Maphumulo V; Chinyama M; Chabu E; Mudenda M; Wong C; Fawzy M; Callahan R
Reprod Health; 2023 Apr; 20(1):65. PubMed ID: 37118835
[TBL] [Abstract][Full Text] [Related]
8. Design of an Implant for Long-Acting HIV Pre-Exposure Prophylaxis: Input from South African Health Care Providers.
Krogstad EA; Montgomery ET; Atujuna M; Minnis AM; O'Rourke S; Ahmed K; Bekker LG; van der Straten A
AIDS Patient Care STDS; 2019 Apr; 33(4):157-166. PubMed ID: 30932697
[TBL] [Abstract][Full Text] [Related]
9. Making the Case for Joint Decision-Making in Future Multipurpose Prevention Technology (MPT) Choice: Qualitative Findings on MPT Attribute Preferences from the CUPID Study (MTN-045).
Bhushan NL; Musara P; Hartmann M; Stoner MCD; Shah SR; Nabukeera J; Rukundo I; Mutero P; Lewis MA; Piper J; Shapley-Quinn MK; Etima J; Minnis AM
J Int AIDS Soc; 2022 Oct; 25(10):e26024. PubMed ID: 36254362
[TBL] [Abstract][Full Text] [Related]
10. Giving voice to the end-user: input on multipurpose prevention technologies from the perspectives of young women in Kenya and South Africa.
Minnis AM; Krogstad E; Shapley-Quinn MK; Agot K; Ahmed K; Danielle Wagner L; van der Straten A;
Sex Reprod Health Matters; 2021 Dec; 29(1):1927477. PubMed ID: 34224341
[TBL] [Abstract][Full Text] [Related]
11. Preferred Product Attributes of Potential Multipurpose Prevention Technologies for Unintended Pregnancy and Sexually Transmitted Infections or HIV Among U.S. Women.
Hynes JS; Sheth AN; Lathrop E; Sales JM; Haddad LB
J Womens Health (Larchmt); 2019 May; 28(5):665-672. PubMed ID: 30615569
[No Abstract] [Full Text] [Related]
12. Interest in multipurpose prevention of HIV and pregnancy: perspectives of women, men, health professionals and community stakeholders in two vaginal gel studies in southern Africa.
Woodsong C; Musara P; Chandipwisa A; Montgomery E; Alleman P; Chirenje M; Chipato T; Martinson F; Hoffman I
BJOG; 2014 Oct; 121 Suppl 5():45-52. PubMed ID: 25335840
[TBL] [Abstract][Full Text] [Related]
13. Interest in multipurpose prevention technologies to prevent HIV/STIs and unintended pregnancy among young women in the United States.
Hynes JS; Sales JM; Sheth AN; Lathrop E; Haddad LB
Contraception; 2018 Mar; 97(3):277-284. PubMed ID: 29055782
[TBL] [Abstract][Full Text] [Related]
14. The Promise of the Dual Prevention Pill: A Framework for Development and Introduction.
Friedland BA; Mathur S; Haddad LB
Front Reprod Health; 2021 Jun; 3():. PubMed ID: 34318291
[TBL] [Abstract][Full Text] [Related]
15. Equipping providers to offer novel MPTs: Developing counseling messages for the Dual Prevention Pill in clinical studies and beyond.
Segal K; Harris DM; Carmone A; Haddad LB; Hadigal S; Hatzold K; Jones C; Lathrop E; Mason J; Mikulich M
Front Reprod Health; 2023; 5():1155948. PubMed ID: 37284490
[TBL] [Abstract][Full Text] [Related]
16. A qualitative study to explore healthcare providers' perspectives on barriers and enablers to early detection of breast and cervical cancers among women attending primary healthcare clinics in Johannesburg, South Africa.
Tshabalala G; Blanchard C; Mmoledi K; Malope D; O'Neil DS; Norris SA; Joffe M; Dietrich JJ
PLOS Glob Public Health; 2023; 3(5):e0001826. PubMed ID: 37159437
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing the uptake of a mono-PrEP implant for the prevention of HIV: Males' perspectives from three South African provinces.
Mthimkhulu N; Chidumwa G; Kutywayo A; Mataboge P; Martin CE; Kwatsha K; Makalela N; Mazibuko M; Butler V; Mullick S
PLoS One; 2024; 19(1):e0296341. PubMed ID: 38166044
[TBL] [Abstract][Full Text] [Related]
18. A strategic action framework for multipurpose prevention technologies combining contraceptive hormones and antiretroviral drugs to prevent pregnancy and HIV.
Young Holt B; Dellplain L; Creinin MD; Peine KJ; Romano J; Hemmerling A
Eur J Contracept Reprod Health Care; 2018 Oct; 23(5):326-334. PubMed ID: 30247084
[TBL] [Abstract][Full Text] [Related]
19. How might we motivate uptake of the Dual Prevention Pill? Findings from human-centered design research with potential end users, male partners, and healthcare providers.
Nyagah W; Segal K; Feltham J; Ash A; Major J; Masani M
Front Reprod Health; 2023; 5():1254953. PubMed ID: 38023531
[TBL] [Abstract][Full Text] [Related]
20. Multipurpose prevention technologies: products in development.
Friend DR; Clark JT; Kiser PF; Clark MR
Antiviral Res; 2013 Dec; 100 Suppl():S39-47. PubMed ID: 24188708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
